20912 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Sub-classes:COMPOSITIONS AND METHODS FOR TREATING BIOFILMS AND NEUTROPHIL EXTRACELLULAR TRAP FORMATION
#2VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCER
#3Modulation Of Tumor Immunity By Protein-Mediated O2 Delivery
#4IMMUNOTOXIN FOR CANCER IMMUNOTHERAPY
#5GLYCOTARGETING THERAPEUTICS
#6RNA GUIDED ERADICATION OF HERPES SIMPLEX TYPE I AND OTHER RELATED HERPESVIRUSES
#7COMPOSITIONS AND METHODS FOR COMPARTMENT-SPECIFIC CARGO DELIVERY
#8Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#9METHOD OF TREATING NEUROINFLAMMATORY SYMPTOMS OF CENTRAL NERVOUS SYSTEM (CNS) DISORDERS BY ADMINISTRATION OF CHOLESTEROL DEPENDENT CYTOLYSINS (CDC)
#10IMMUNOMODULATORY COMPOSITIONS AND METHODS
#11Nanoparticles and Method for Targeting the Nanoparticles to Bacterial Biofilms Using Bacterial Surface Proteins
#12METHOD FOR TREATMENT OF AUTISM SPECTRUM DISORDER, MOUSE FOR MONITORING AUTISM SPECTRUM DISORDER, AND METHOD FOR SCREENING CANDIDATE MATERIAL FOR PREVENTION OR TREATMENT OF AUTISM SPECTRUM DISORDER
#13METHODS OF TREATING MALIGNANT GLIOMAS
#14SPRAY DRIED FORMULATION OF A CHOLERA TOXIN B SUBUNIT VARIANT
#15ANTI-PATHOGEN COMPOSITION AND METHODS OF USE THEREOF
#16IMMUNOTHERAPY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASE
#17MICROBIOTA ANALOGS OF TUMOR ASSOCIATED ANTIGENS AND USES THEREOF
#18TREATING AUTOIMMUNE DISEASES WITH INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR LIGAND CONJUGATED TO AN AGENT
#19SOLID LIPID NANOPARTICLES FOR ENCAPSULATION AND DELIVERY OF BIOACTIVE COMPOUNDS AND METHODS OF MAKING THE SAME
#20PHARMACEUTICAL AGENT TO PREVENT THE ADVERSE EFFECTS OF ROTAVIRUS NSP4 PROTEIN
#21OXYTOCIN-MIMETIC COMPOSITIONS AND USES THEREOF
#22ANTIMICROBIAL THERAPY
#23POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5
#24PHEROMONICIN AGAINST SARS-COV-2 AND USE THEREOF
#25COMPOSITIONS AND METHODS FOR TREATING CANCER
#26PROTEIN INHIBITORS OF CLOSTRIDIUM DIFFICILE TOXIN B
#27PEGYLATED LIPOSOMES AND USES THEREOF
#28SOLID LIPID NANOPARTICLES FOR ENCAPSULATION AND DELIVERY OF BIOACTIVE COMPOUNDS AND METHODS OF MAKING THE SAME
#29EXTRACELLULAR VESICLES FUNCTIONALIZED WITH AN ERV SYNCITIN AND USES THEREOF FOR CARGO DELIVERY
#30Neurotoxin Compositions with Increased Efficacy and Effect Duration
#31THIOSTREPTON COMPOSITIONS AND PREPARATION THEREOF
#32SYSTEMS AND METHODS FOR BOTULINUM TOXIN OR OTHER DRUG INJECTIONS FOR MEDICAL TREATMENT
#33ANTIBACTERIAL POLYPEPTIDES
#34CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#35USE OF MICROBIAL HEMEPROTEIN FOR INCREASING MUCIN PRODUCTION IN GUT TRACT
#36THERAPEUTIC AGENT
#37DESIGN AND CONSTRUCTION OF EVOLUTIONARY-GUIDED "SELECTION GENE DRIVE" THERAPY
#38Aqueous liquid extract of Spirulina for the prevention and/or treatment of chemically induced peripheral neuropathy and their symptoms, composition and use thereof
#39CLOSTRIDIUM HISTOLYTICUM ENZYMES AND METHODS FOR THE USE THEREOF
#40Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae
#41Viral Vectors For Treating Neurogenic Detrusor Overactivity
#42COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME
#43COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME
#44CHIMERIC BACTERIOCINS AND METHOD FOR THE CONTROL OF PSEUDOMONAS
#45PERITONEAL DIALYSIS FLUID COMPOSITION COMPRISING A COMPLEMENT INHIBITOR
#46COMPOSITION FOR PREVENTING OR TREATING GRAFT-VERSUS-HOST DISEASE COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS EFFECTIVE COMPONENT
#47METHODS AND COMPOSITIONS FOR TREATING CLOSTRIDIODES DIFFICILE INFECTIONS
#48FISH REARING COMPOSITION, AND COMPOSITION FOR PREVENTING OR TREATING FISH DISEASES
#49PURIFIED ANTHELMINTIC COMPOSITIONS AND RELATED METHODS
#50LANTHIPEPTIDES AND METHODS OF USE
#51COSMETIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS
#52HAPLOTYPE-BASED TREATMENT OF RP1 ASSOCIATED RETINAL DEGENERATIONS
#53FISH REARING COMPOSITION, AND COMPOSITION FOR PREVENTING OR TREATING FISH DISEASES
#54USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM
#55ANTIMICROBIAL TYPE-II BACTERIOCINS
#56METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS
#57METHODS AND COMPOSITIONS OF TREATING BIOLFILM-RELATED DISEASES
#58METHODS OF TREATING MALIGNANT GLIOMAS
#59DRUGS, EXPRESSION VECTORS, AND THEIR APPLICATIONS IN THE TREATMENT OF NAFLD AND RELATED DISEASES
#60SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF
#61Improved Lyophilized Formulation
#62Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy
#63Pharmaceutical compositions comprising collagenase I and collagenase II
#64COMPOSITIONS AND METHODS FOR THE PRODUCTION OF CYSTEINE
#65MATERIALS AND METHODS FOR PREVENTING OR REDUCING TOXICITY TO ORGANOPHOSPHATES AND OTHER TOXIC MATERIALS
#66SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES
#67BROAD HOST RANGE CONJUGATIVE PLASMIDS
#68GENE THERAPY WITH THE GENES HOKD AND LDRB FOR CANCER TREATMENT
#69COMPOSITION FOR DECOMPOSITION OF TRYPSIN OR TMPRSS2
#70POLYMERIC FORMS OF H-NOX PROTEINS
#71SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#72PHARMACEUTICAL COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS
#73Combination Therapy of Immunotoxin and Checkpoint Inhibitor
#74SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#75NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#76Bacteriocin for new application
#77AEROSOL COMPOSITION FOR PULMONARY DELIVERY OF FLAGELLIN
#78PHARMACEUTICAL COMPOSITION COMPRISING MACROCOSINE COMPOUND AND METHOD FOR PREPARING MACROCOSINE COMPOUND
#79COMPOSITIONS FOR CONTROL OF HUMAN AND ANIMAL PARASITIC NEMATODES AND METHODS OF USE
#80Surface layer protein a (SlpA) as a therapeutic agent for the treatment of inflammatory diseases
#81NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#82Viral Vectors For Treating Neurogenic Detrusor Overactivity
#83USE OF PERTUSSIS TOXIN AS A THERAPEUTIC AGENT
#84CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#85MULTI SPECIFIC MOLECULES
#86CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#87FUSION PROTEINS AND METHODS FOR STIMULATING PLANT GROWTH, PROTECTING PLANTS, AND IMMOBILIZING BACILLUS SPORES ON PLANTS
#88Bacteriocin for new application
#89ARTHROSPIRA FOR USE IN THE TREATMENT OF DISEASES
#90PSEUDOMONAS BACTERIOPHAGE AND USES THEREOF
#91H-NOX PROTEINS FOR TREATING CARDIOVASCULAR AND PULMONARY CONDITIONS
#92Purified anthelmintic compositions and related methods
#93METHODS AND COMPOSITIONS FOR TREATING CLOSTRIDIODES DIFFICILE INFECTIONS
#94Viral Vectors For Treating Neurogenic Detrusor Overactivity
#95Use of pertussis toxin as a therapeutic agent
#96CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#97USE OF METHANOBACTIN FOR TREATMENT OF IRON-RELATED DISEASES
#98Cancer Stem Cell Targeted Cancer Vaccines
#99VIRAL TREATMENT
#100COMPOSITION FOR SUPPRESSING DETERIORATION OF OR ENHANCING MEMORY LEARNING FUNCTION AND/OR COGNITIVE FUNCTION
#101METHODS AND COMPOSITIONS FOR ENHANCING THE POTENCY OF SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY
#102COMBINATION THERAPIES OF AMUC_1100 AND IMMUNE CHECKPOINT MODULATORS FOR USE IN TREATING CANCERS
#103SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES, SHIGA TOXIN EFFECTOR SCAFFOLDS, AND CELL-TARGETING MOLECULES FOR SITE-SPECIFIC CONJUGATION
#104VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCER
#105COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME
#106Proteins for the treatment of epithelial barrier function disorders
#107MATERIALS AND METHODS FOR INHIBITING A VIRAL INFECTION, INCLUDING A CORONAVIRUS INFECTION
#108NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES
#109PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
#110COMPOSITION AND USE
#111FUNCTIONALIZED SHIGA TOXIN B-SUBUNIT (STxB) PROTEINS AND CONJUGATES THEREOF
#112METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION
#113TREATMENT OF LOWER LIMB SPASTICITY
#114CHIMERIC KLEBICINS
#115Skin Probiotics
#116METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE
#117CONTROL OF MICROORGANISMS IN MICROBIAL COMMUNITIES
#118TREATMENT METHODS USING BOTULINUM TOXINS
#119METHODS OF TREATING INFECTIONS BY BLOCKING PATHOGEN MIMICS OF CD47
#120RESPIRATORY VIRUS NUCLEIC ACID VACCINES
#121ENHANCEMENT OF ANTITUMOR EFFECT OF IMMUNE CHECKPOINT INHIBITOR THROUGH ADMINISTRATION OF INTESTINAL RUMINOCOCCACEAE BACTERIUM
#122Non-protein Clostridial toxin compositions
#123Non-protein clostridial toxin compositions
#124Lyophilized formulation
#125COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME
#126PHAGE AND TRANSDUCTION PARTICLES
#127SYSTEMS AND METHODS FOR DELIVERY OF A THERAPEUTIC AGENT
#128Bacterial Vehicle for Engineering of Non-Phagocytic Immune Cells
#129NOVEL COMPOSITION FOR PREVENTION OR TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIOUS DISEASE
#130Pulmonary administration of pyocins for treating bacterial respiratory infections
#131METHODS AND COMPOSITIONS FOR TREATING PERIODONTAL DISEASE
#132SYSTEMS AND METHODS FOR DELIVERY OF A THERAPEUTIC AGENT
#133BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN
#134FORMULATIONS OF BIOLOGICS FOR INTRAVESICAL INSTILLATION
#135IMMUNOGENIC COMPOSITIONS
#136PLATELETS LOADED WITH ANTI-CANCER AGENTS
#137Composition comprising an algal proteoglycan extract and use thereof
#138PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF A GUANYLATE CYCLASE C (GUCY2C) AGONIST AND A SHORT-CHAIN FATTY ACID OR PRODRUG THEREOF
#139Identification And Synthesis Of Drug Candidates Derived From Human Microbiome Metasecretome Proteins
#140DIAGNOSTICS AND USE OF QUORUM SENSING MOLECULES IN MUSCLE WASTING
#141Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
#142Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins
#143IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
#144NOVEL ANTIBIOTIC COMPOSITIONS AND METHODS OF MAKING OR USING THE SAME
#145ANTIBACTERIAL PRODUCTS
#146NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#147CLOSTRIDIUM DIFFICILE ANTIGENS
#148MEANS AND METHODS FOR TREATING COPPER-RELATED DISEASES
#149Compositions and uses of Oligo-chromopeptides and methods of making
#150Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets
#151Materials and methods for inhibiting a viral infection, including a coronavirus infection
#152MEDICAMENT FOR KILLING TUMOR CELLS
#153USE OF PHYCOBILIPROTEIN (PBP) TO INHIBIT OR TREAT SARS-COV-2 INFECTION
#154VIRAL VECTORS FOR TREATING NEUROGENIC DETRUSOR OVERACTIVITY
#155ANTHELMINTIC COMPOSITIONS AND METHODS
#156PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS
#157TREATMENT OF VIRAL INFECTION
#158VARIANTS OF SAC7D AND THEIR USE IN CANCER THERAPY
#159GLYCOTARGETING THERAPEUTICS
#160MODULATING ANTI-TUMOR IMMUNITY
#161Methods of Treating Cancer Using Checkpoint Inhibitors in Combination with Purine Cleaving Enzymes
#162LASSO PEPTIDES FOR TREATMENT OF CANCER
#163Microbiota-Derived Proteins Inducing Il-10 Release From Human Cells And Uses Thereof
#164COMPOSITIONS AND METHODS FOR COMPARTMENT-SPECIFIC CARGO DELIVERY
#165TARS DERIVED FROM AKKERMANSIA MUCINIPHILA OR FRAGMENT THEREOF, AND USE THEREOF
#166Aqueous liquid extract of Spirulina for the prevention and/or treatment of chemically induced peripheral neuropathy and their symptoms, composition and use thereof
#167Heme sequesting peptides and uses therefor
#168POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY
#169ANTICANCER COMPOSITION COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS ACTIVE INGREDIENT
#170LANTIBIOTIC SOLUTION AGAINST BACTERIAL INFECTIONS
#171SYSTEM AND METHOD FOR COMBATING MYCOBACTERIUM TUBERCULOSIS INFECTIONS
#172CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR LEUKEMIAS
#173Purified anthelmintic compositions and related methods
#174FUSED PROTEIN OF AN ANTIBODY WHICH RECOGNIZES CANCER-CELLS AND A STREPTAVIDIN MUTANT
#175NEUROTOXINS FOR USE IN INHIBITING CGRP
#176Method for killing bacteria with an engineered postbiotic
#177FUSION PROTEINS AND USES THEREOF
#178Formulations for Prevention or Reduction of C. Difficile Infections
#179RELEASE OF GROWTH FACTORS AT WOUND HEALING STAGES
#180Proteins for the treatment of epithelial barrier function disorders
#181C-terminal fragment of tetanus toxin (HC) for treatment of depression
#182SPRAY DRIED FORMULATION OF A CHOLERA TOXIN B SUBUNIT VARIANT
#183NOVEL LACTIC ACID BACTERIA STRAIN - ANTIBACTERIAL PEPTIDES PRODUCED BY SAID STRAIN AND RELATED PHARMACEUTICAL COMPOSITIONS
#184Methods and compositions for controlling or reducing pests
#185Methods and compositions based on diphtheria toxin-interleukin-3 conjugates
#186Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#187SYSTEM AND METHOD FOR COMBATING INFECTIONS DUE TO ANTIBIOTIC INDUCED PATHOGENS
#188CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#189Protein inhibitors of clostridium difficile toxin b
#190GENETICALLY ENGINEERED MICROORGANISMS AND METHODS OF USE
#191COMPOSITION FOR PREVENTING OR TREATING GRAFT-VERSUS-HOST DISEASE COMPRISING TLR5 AGONIST DERIVED FROM FLAGELLIN AS EFFECTIVE COMPONENT
#192LACTATE RESPONSE SYSTEM AND METHODS
#193RESPIRATORY VIRUS NUCLEIC ACID VACCINES
#194PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
#195XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF
#196LANTIBIOTICS AND LANTIBIOTIC-PRODUCING BACTERIA
#197Modulation of tumor immunity by protein-mediated Odelivery
#198Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
#199MODIFIED MITOCHONDRION AND METHODS OF USE THEREOF
#200NOVEL ANTIMICROBIAL COMPOUND AND USES THEREOF
#201Recombinant Bacteria And Uses Thereof
#202Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
#203METHODS FOR PREPARING ALUMINUM PRECIPITATE COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES
#204Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use
#205IMMUNOMODULATORY COMPOSITIONS AND METHODS
#206PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
#207ADHESIVE FOR OSSEOINTEGRATED PERCUTANEOUS DEVICES
#208PROTECTION AGAINST STRESS-MEDIATED DAMAGE FROM IONIZING RADIATION
#209SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
#210STRUCTURED GELS
#211Autotransporter-mediated display of complement receptor ligands by bacterial immunogens
#212Compositions and Methods for Treatment of Duchenne Muscular Dystrophy
#213MESOPHILIC ARGONAUTE SYSTEMS AND USES THEREOF
#214IMMUNOTHERAPY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASE
#215CBM USES
#216IMMUNOMODULATORY & ONCOLYTIC MINICELLS AND METHODS OF USE
#217COMBINATIONS OF ENGINEERED ANTIMICROBIAL PROBIOTICS FOR TREATMENT OF GASTROINTESTINAL TRACT PATHOGENS
#218Polymeric forms of H-NOX proteins
#219METHOD FOR TREATMENT OF AUTISM SPECTRUM DISORDER, MOUSE FOR MONITORING AUTISM SPECTRUM DISORDER, AND METHOD FOR SCREENING CANDIDATE MATERIAL FOR PREVENTION OR TREATMENT OF AUTISM SPECTRUM DISORDER
#220ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC
#221ENGINEERED FLAGELLIN-DERIVED COMPOSITIONS AND USES
#222COMPOSITION FOR PROMOTING ANTIMICROBIAL PEPTIDE PRODUCTION
#223PROTEINS WITH DIAGNOSTIC AND THERAPEUTIC USES
#224COMPOSITION AND METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#225METHODS AND COMPOUNDS FOR TARGETING SORTILIN RECEPTORS AND INHIBITING VASCULOGENIC MIMICRY
#226NUTRITIONAL SUPPLEMENTS FOR ANIMAL HEALTH AND DEVELOPMENT
#227ANTI-PATHOGENIC ACTIVITY OF A BIFUNCTIONAL PEPTIDOGLYCAN/CHITIN HYDROLASE
#228Antimicrobial type-II bacteriocins
#229Pharmaceutical compositions, vaccines and their uses in the prevention or treatment of a persistent infection or of cancer
#230COMPOSITIONS FOR THE INHIBITION OF GIARDIA LAMBLIA
#231Polypeptides binding to human complement C5
#232USE OF MAM POLYPEPTIDES FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS
#233Compositions and methods for non-myeloablative conditioning
#234BIOENGINEERED LACTOBACILLUS PROBIOTICS AND THE USES THEREOF
#235Compositions and methods for the production of cysteine
#236CLOSTRIDIUM DIFFICILE ANTIGENS
#237NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#238MEANS AND METHODS FOR TREATING COPPER-RELATED DISEASES
#239C-terminal fragment of tetanus toxin (Hc) for treatment of depression
#240METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS
#241FLAGELLIN COMPOSITIONS AND USES
#242Combination Therapy of Immunotoxin and Checkpoint Inhibitor
#243Method of treating autoimmune inflammatory crohn's disease
#244Composition for preventing or treating infection
#245METHOD FOR DETECTING CANCER CELLS, REAGENT FOR INTRODUCING SUBSTANCE INTO CANCER CELLS, AND COMPOSITION FOR TREATING CANCER
#246COMPOSITIONS FOR PROTECTING SKIN COMPRISING DNA REPAIR ENZYMES AND PHYCOBILIPROTEIN
#247METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES
#248LACTOBACILLUS ACIDOPHILUS SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES
#249TREATMENT OF LOWER LIMB SPASTICITY
#250ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS
#251NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#252BACTERIOTHERAPY AGAINST PROPRIONIBACTERIUM ACNES FOR THE TREATMENT OF ACNE
#253Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof
#254Compositions comprising Sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith
#255Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health
#256METHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS
#257Haplotype-based treatment of RP1 associated retinal degenerations
#258Flagellin-based agents and uses including effective vaccination
#259SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#260ANTHELMINTIC PROBIOTIC COMPOSITIONS AND METHODS
#261Compositions including probiotic bacteria for the expression and secretion of enterocins to control clostridia perfringens-induced necrotic enteritis in livestock and related methods
#262PIRIN POLYPEPTIDE AND IMMUNE MODULATION
#263H-NOX Proteins for Treating Cardiovascular and Pulmonary Conditions
#264Composition for cell transplant, and method for cell transplant
#265METHODS FOR IMPROVING FRAILTY AND AGING
#266Antimicrobial therapy
#267Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#268Peptide interacting with toll-like receptor 2 and the composition comprising the same
#269CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#270ALBUMIN-PROAEROLYSIN PRODRUGS
#271VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT
#272MUTATED E. COLI ENTEROTOXINS AS ANTI-INFLAMMATORY AGENTS
#273Treatment methods using botulinum toxins
#274AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR PREVENTING OR TREATING LIPIDO-CARBOHYDRATE METABOLISM DISORDERS
#275Systems and methods for delivery of a therapeutic agent
#276IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
#277Methods, reagents and kits for detecting minimal residual disease
#278Use of toll-like receptor agonist for treating cancer
#279Plantaricin NC8 alpha beta markedly enhances the effects of antibiotics
#280Lactoferricin and lactoferrampin for treating infections
#281Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders
#282Antifungal and antimicrobial uses of containing compositions
#283Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy
#284Fusion proteins and methods for stimulating plant growth, protecting plants, and immobilizing bacillus spores on plants
#285COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME
#286MODULATION OF HYPOXIA ASSOCIATED WITH STROKE
#287FLAGELLIN RELATED POLYPEPTIDES AND USES THEREOF
#288Fusion protein containing trail and IgG binding domain and the uses thereof
#289Cancer stem cell targeted cancer vaccines
#290Anti-pathogen composition and methods of use thereof
#291PHYCOCYANIN COMPOSITION FOR USE IN INHIBITING BONE RESORPTION
#292Use of pertussis toxin as a therapeutic agent
#293Inhibitor of RNA polymerase II
#294Polypeptide and immune modulation
#295Proteins and nucleic acids useful in vaccines targeting
#296Treatment of infection by human enterovirus D68
#297PROBIOTIC DELIVERY OF GUIDED ANTIMICROBIAL PEPTIDES
#298COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF IMMUNE COMPLEX DISEASE
#299COMPOSITIONS AND METHODS FOR TREATING DISEASE USING SALMONELLA T3SS EFFECTOR PROTEIN (SipA)
#300Process for the linear synthesis of gram-positive class II bacteriocins and compositions and uses thereof